金吾财讯 | BioNTech(BNTX)在周五提交的文件中表示，已与美国国立卫生研究院和宾夕法尼亚大学就其 COVID-19 疫苗相关特许权使用费支付达成两项单独的和解协议。这家德国公司与美国制药巨头辉瑞公司合作生产 COVID-19 疫苗，该公司表示，根据协议，它将向该美国机构支付 7.915 亿美元。
BioNTech 已从 NIH 等实体获得了某些专利的许可，因此美国政府应支付一定的专利使用费。另外，该公司将向宾夕法尼亚大学支付 4.67 亿美元，该大学将驳回针对该疫苗制造商的指控其支付特许权使用费过少的诉讼。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.